# Role of NLRP3 Inflammasone and Hypoxia in the Severity of Osteoporosis in Patients With Bronchiectasis

> **NCT03467035** · — · UNKNOWN · sponsor: **Chun-Hua Wang, MD** · enrollment: 80 (estimated)

## Conditions studied

- Bronchiectasis Adult
- Osteoporosis, Osteopenia

## Interventions

- **OTHER:** Inflammasone

## Key facts

- **NCT ID:** NCT03467035
- **Lead sponsor:** Chun-Hua Wang, MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-21
- **Primary completion:** 2018-12-31
- **Final completion:** 2019-06-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2018-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03467035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03467035, "Role of NLRP3 Inflammasone and Hypoxia in the Severity of Osteoporosis in Patients With Bronchiectasis". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT03467035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*